PROFUND VP PHARMACEUTICALS is a registered fund series of ProFunds (series S000003975). Net assets $10.2M as of 2026-03-31. Index fund.
Showing 15 of 136 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Enliven Therapeutics Inc | — | $239K | 235.19% |
| Enliven Therapeutics Inc | — | $239K | 235.19% |
| Corcept Therapeutics Inc. | — | $224K | 220.05% |
| Corcept Therapeutics Inc. | — | $224K | 220.05% |
| Terns Pharmaceuticals Inc. | — | $211K | 207.59% |
| Terns Pharmaceuticals Inc. | — | $211K | 207.59% |
| Perrigo Company PLC | — | $205K | 201.65% |
| Perrigo Company PLC | — | $205K | 201.65% |
| Axsome Therapeutics Inc. | — | $198K | 195.14% |
| Axsome Therapeutics Inc. | — | $198K | 195.14% |
| Innoviva Inc | — | $195K | 191.42% |
| Innoviva Inc | — | $195K | 191.42% |
| Merck & Co., Inc | — | $194K | 190.69% |
| Merck & Co., Inc | — | $194K | 190.69% |
| Pfizer Inc. | — | $193K | 189.43% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $10.2M |
| 2025-12-31 | $10.5M |
| 2025-09-30 | $9.3M |
| 2025-06-30 | $7.7M |
| 2025-03-31 | $8.8M |
| 2024-12-31 | $9.4M |
| 2024-09-30 | $10.4M |
| 2024-06-30 | $9.4M |